Journal Guide

Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical & Experimental Allergy and included with every subscription to the primary research journal.

Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease.Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.Free Access in the Developing WorldFree online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).Online OpenAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.

Clinical & Experimental Ophthalmology is the official journal of The Royal Australian and New Zealand College of Ophthalmologists. The journal primarily publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research in ophthalmology and vision science. Short articles are also welcomed for publication under the headings 'Clinicopathological Report', 'Clinical and Surgical Techniques', 'History of Ophthalmology' and 'Letters to the Editor'. Manuscripts dealing with 'Ophthalmic Hypothesis', and 'Developing World Ophthalmology' are encouraged. Reports of interesting and original cases may be published as 'Photographic Essays' or 'Clinical Case Notes' in Letters to the Editor. The acceptance criteria for all papers are the quality, originality and significance of the research. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers, a Section Editor and the Editor in an average time of 2.5 months. The average time from original submission to publication, for manuscripts that are accepted, is 10 months. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts, figures and correspondence, as material cannot be returned. Final acceptance or rejection rests with the Editorial Board.

Clinical & Translational Immunology (CTI) is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. Brought to you by the editorial team of Immunology & Cell Biology, CTI covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.

Now Indexed in PubMed Central.

Each issue of Clinical Reviews in Bone and Mineral Metabolism is devoted to a single theme aimed at integrating new information, both basic and clinical science, into the context of clinical practice. For each review article, there is an interval of 6-9 months between invitation to authors and publication. Each issue features guest editors recognized for their own contributions to the field, thereby ensuring that the right colleagues have been invited to review the most current information.

CLINICAL ANATOMY is the Official Journal of the American Association of Clinical Anatomists and the British Association of Clinical Anatomists . The goal of CLINICAL ANATOMY is to provide a medium for the exchange of current information between anatomists and clinicians. This journal embraces anatomy in all its aspects as applied to medical practice. Furthermore, the journal assists physicians in keeping abreast of new methodologies for patient management and informs educators of new developments in clinical anatomy and teaching techniques. CLINICAL ANATOMY publishes original and review articles of scientific, clinical, and educational interest. Papers covering the application of anatomic principles to the solution of clinical problems and/or the application of clinical observations to expand anatomic knowledge are welcomed.

Clinical Autonomic Research aims to draw together and disseminate research work from various disciplines and specialties dealing with clinical problems resulting from autonomic dysfunction. Areas to be covered include: cardiovascular system, neurology, diabetes, endocrinology, urology, pain disorders, ophthalmology, gastroenterology, toxicology and clinical pharmacology, skin infectious diseases, renal disease.This journal is an essential source of new information for everyone working in areas involving the autonomic nervous system. A major feature of Clinical Autonomic Research is its speed of publication coupled with the highest refereeing standards.

Manuscripts are categorized as Analytical or Clinical Investigations and may be offered as Full Papers, Short Communications, or Letters. Opinion pieces and Special Reports are welcome, but contributors are encouraged to contact the Editor-in-Chief to avoid conflict with other forthcoming publications.

The science of biomechanics helps explain the causes of musculoskeletal disorders and provides assistance to the clinician in the evaluation of treatment methods. Clinical Biomechanics aims to strengthen the link between clinic and laboratory by publishing biomechanics research which helps to explain the causes of musculoskeletal disorders and which provides knowledge contributing to improved clinical management.

A peer review system is employed and every attempt is made to process and publish papers promptly.

Clinical Biomechanics explores all facets of musculoskeletal biomechanics with an emphasis on clinical management. The role of basic, as well as medical, science is recognized in a clinical context. The readership of the journal closely reflects its contents, being a balance of scientists, engineers and clinicians.

The contents are in the form of research papers, brief reports, review papers and correspondence, whilst special interest issues and supplements are published from time to time.

Disciplines covered include orthopaedic and sports biomechanics, bioengineering, biophysics, ergonomics, kinetics, clinical science, physical therapeutics and rehabilitation.

The journal is affiliated to the http://www.esbiomech.org/European Society of Biomechanics http://asb-biomech.org/American Society of Biomechanics http://www.isbweb.org/International Society of Biomechanics and the Taiwanese Society of Biomechanics

First Annual Focus Meeting of the EPUAP: 16-17 April, 2012, Tel Aviv University, Tel Aviv, Israel /inca/publications/misc/israel.pdfEPUAP Tel Aviv

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/725535/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

Clinical Cancer Research, is a journal of the American Association for Cancer Research whose focus is to publish innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. Clinical Cancer Research is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. The journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease. Clinical Cancer Research will publish articles that provide the reader with knowledge and information to impact the natural history of malignant disease by providing better care for patients with cancer.

Clinical Case Reports is different to other case report journals. Our aim is to directly improve global health outcomes and share clinical knowledge using case reports to convey important best practice messages. We welcome case reports, clinical images, and procedural videos from all areas of Medicine, Nursing, Dentistry, and Veterinary Science.